Related Experiment Video
Updated: Apr 27, 2026

04:45
Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
Published on: May 10, 2021
4.6K
Toward microendoscopic electrical impedance tomography for intraoperative surgical margin assessment
IEEE Transactions on Bio-Medical Engineering
|June 22, 2014
Summary
A new microendoscopic electrical impedance tomography (EIT) probe offers real-time intraoperative assessment of surgical margins during prostatectomy. This device uses electrical properties to distinguish between cancerous and healthy tissue, potentially improving surgical outcomes.
Area of Science:
- Biomedical Engineering
- Medical Devices
- Surgical Technology
Background:
- Current prostate surgery lacks real-time margin assessment, delaying intervention until after prostatectomy.
- Pathological assessment post-surgery is too late for immediate surgical adjustments.
Purpose of the Study:
- To develop and evaluate a microendoscopic electrical impedance tomography (EIT) probe for intraoperative surgical margin assessment.
- To assess the probe's ability to differentiate between benign and malignant prostate tissue based on electrical properties.
Main Methods:
- Construction of a microendoscopic EIT probe with eight 0.6-mm electrodes in a 5-mm tip for laparoscopic access.
- Testing the probe's sensitivity volume, including experiments with gelatin inclusions and porcine tissue.
- Evaluating the probe's resolution and ability to distinguish tissue types at a sub-millimeter scale.
Main Results:
- The EIT probe demonstrated sensitivity within a circular area of 9.1 mm² and a maximum depth of 1.5 mm.
- The probe successfully distinguished between muscle and adipose tissue at a scale of approximately 500 μm.
- Preliminary results indicate the feasibility of EIT within a probe suitable for a 12-mm laparoscopic port.
Conclusions:
- The developed microendoscopic EIT probe shows promise for real-time intraoperative margin assessment in prostate surgery.
- This technology could enable immediate surgical decisions, potentially improving patient outcomes.
- Further development is warranted to validate its clinical utility in distinguishing prostate tissue pathologies.

